Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARNI J SANDERS

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1215933304
CMS profile
326827
Location
NEW HYDE PARK, NY

General Payments · PY2018–2024

$2,359.79

  • Reported across 136 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$247.12

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $247.12 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $324.27 19
PY2019 $263.96 15
PY2020 $110.73 6
PY2021 $258.69 13
PY2022 $644.99 37
PY2023 $510.03 30
PY2024 $247.12 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Agile Therapeutics, Inc. $20.72 01/23/2024 Food and Beverage Undisputed 01/23/2026 1154841166 CMS
Astellas Pharma US Inc $18.65 02/26/2024 Food and Beverage Undisputed 01/23/2026 1139316730 CMS
Biogen, Inc. $20.79 03/27/2024 Food and Beverage Undisputed 01/23/2026 1104873190 CMS
Daiichi Sankyo Inc. $25.82 05/07/2024 Food and Beverage Undisputed 01/23/2026 1089478205 CMS
Daiichi Sankyo Inc. $19.87 06/19/2024 Food and Beverage Undisputed 01/23/2026 1089478207 CMS
Evofem Biosciences, Inc. $21.04 02/21/2024 Food and Beverage Undisputed 01/23/2026 1091270907 CMS
Exeltis, USA Inc. $20.96 04/16/2024 Food and Beverage Undisputed 01/23/2026 1150003872 CMS
MAYNE PHARMA COMMERCIAL LLC $4.50 01/10/2024 Food and Beverage Undisputed 01/23/2026 1154687055 CMS
MAYNE PHARMA COMMERCIAL LLC $4.58 04/02/2024 Food and Beverage Undisputed 01/23/2026 1154687057 CMS
MAYNE PHARMA COMMERCIAL LLC $10.43 05/22/2024 Food and Beverage Undisputed 01/23/2026 1154687059 CMS
Merck Sharp & Dohme LLC $27.21 02/06/2024 Food and Beverage Undisputed 01/23/2026 1141920044 CMS
Organon Llc $0.70 03/20/2024 Food and Beverage Undisputed 01/23/2026 1136194802 CMS
Organon Llc $17.34 03/20/2024 Food and Beverage Undisputed 01/23/2026 1136194804 CMS
Organon Llc $19.37 05/15/2024 Food and Beverage Undisputed 01/23/2026 1136194806 CMS
Organon Llc $0.51 05/15/2024 Food and Beverage Undisputed 01/23/2026 1136194808 CMS
Sumitomo Pharma America, Inc. $14.63 01/31/2024 Food and Beverage Undisputed 01/23/2026 1148914216 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.